当前位置:首页 >财报库 > 报告详情

美敦力公司Medtronic(MDT)2026财年第三季度财报(10-Q)「NYSE」(英文版)(68页).pdf

上传人: 1****1 编号:1145197 2026-02-28 68页 1.49MB

下载:

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,DC 20549FORM 10-QQUARTERLY REPORT UNDER SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period endedJanuary 23,2026Transition report pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934.For the tran

2、sition period from _ to _Commission File Number 001-36820Medtronic plc(Exact name of registrant as specified in its charter)Ireland98-1183488(State of incorporation)(I.R.S.Employer Identification No.)Building Two,Parkmore Business Park WestGalway,Ireland(Address of principal executive offices)+353 1

3、 438-1700(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading SymbolName of each exchange on which registeredOrdinary shares,par value$0.0001 per shareMDTNew York Stock Exchange1.125%Senior Notes due 2027MDT/27New York

4、 Stock Exchange0.375%Senior Notes due 2028MDT/28New York Stock Exchange3.000%Senior Notes due 2028MDT/28ANew York Stock Exchange3.650%Senior Notes due 2029MDT/29New York Stock Exchange2.950%Senior Notes due 2030MDT/30New York Stock Exchange1.625%Senior Notes due 2031MDT/31New York Stock Exchange1.00

5、0%Senior Notes due 2031MDT/31ANew York Stock Exchange3.125%Senior Notes due 2031MDT/31BNew York Stock Exchange0.750%Senior Notes due 2032MDT/32New York Stock Exchange3.375%Senior Notes due 2034MDT/34New York Stock Exchange3.875%Senior Notes due 2036MDT/36New York Stock Exchange2.250%Senior Notes due

6、 2039MDT/39ANew York Stock Exchange1.500%Senior Notes due 2039MDT/39BNew York Stock Exchange1.375%Senior Notes due 2040MDT/40ANew York Stock Exchange4.150%Senior Notes due 2043MDT/43ANew York Stock Exchange4.200%Senior Notes due 2045MDT/45New York Stock Exchange1.750%Senior Notes due 2049MDT/49New Y

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **财务表现**:2026财年前三季度净销售额265.57亿美元,同比增长8%;净利润35.57亿美元,同比略降1.8%。 2. **业务分部**:心血管部门净销售额101.79亿美元(占比38%),神经科学部门75.36亿美元(占比28%),医疗外科部门64.28亿美元(占比24%)。 3. **债务与投资**:总债务278.8亿美元,持有投资72.55亿美元(主要为可出售债务证券);现金及 equivalents 11.47亿美元。 4. **重组计划**:批准MiniMed分拆相关重组,预计产生3亿至5亿美元重组费用,涉及员工终止福利等。 5. **衍生品与对冲**:使用外汇衍生品管理汇率风险,现金流对冲工具未实现损失1.16亿美元(税后)。
**营收增长动力?** **债务风险几何?** **重组影响多大?**
客服
商务合作
小程序
服务号
折叠